AUCTORES
Globalize your Research
Review Article | DOI: https://doi.org/10.31579/2641-8975/001
*Corresponding Author: Udaya M Kabadi, Broadlawns Medical Center, Des Moines, University of Iowa.
Citation: Udaya M Kabadi, SGLT2 inhibitors and Ketoacidosis: Epidemiology and Pathophysiology. J Diabetes and Islet Biology, DOI:10.31579/2641-8975/001
Copyright: © 2018 Udaya M Kabadi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation: Udaya M Kabadi, SGLT2 inhibitors and Ketoacidosis: Epidemiology and Pathophysiology. J Diabetes and Islet Biology, DOI:10.31579/2641-8975/001
Received: 08 July 2018 | Accepted: 17 July 2018 | Published: 23 July 2018
Keywords: Keywords
SGLT 2 inhibitors are a recent addition to the armamentarium of agents approved for treatment of hyperglycemia in management of type 2 diabetes. Unfortunately, the agents are fairly expensive with a modest efficacy rendering them to be probably the least cost effective drugs in management of hyperglycemia in subjects with type 2 diabetics. The cost efficacy falls even more because of additional expenses required for management of several short term and long term adverse outcomes causing a decline in quality of life. Ketosis and ketoacidosis are two of the several cautions issued by regulatory agencies and have gained prominence because of their serious nature with an occasional fatality. In this review, epidemiology and pathophysiology of onset of ketoacidosis in subjects administered SGLT2 inhibitors is discussed in order to improve recognition in early stage of the disorder and implement a prompt management strategy to prevent further morbidity, mortality as well as recurrent events.
Ketosis and ketoacidosis are well established metabolic complications of diabetes mellitus of both types, 1 and 2. Fortunately, most subjects recover completely without a specific sequele following appropriate management although occasionally with a lethal outcome or a morbidly especially among children and adolescents (1-5). Onset of ketosis and ketoacidosis is frequently attributed to a precipitant such as acute illness including sepsis, dehydration, myocardial infarction, pregnancy or drug (1-6). However, never in the history of the disorder, ketosis and ketoacidosis have been attributed to any drug used in treatment of the disorder itself. In contrast, SGLT 2 inhibitors are the first class of drugs approved in management of diabetes being directly implicated in onset of ketosis and ketoacidosis (6-27). Acute illness especially genito urinary sepsis and dehydration are apparently the frequent contributors to ketosis and ketoacidosis in subjects treated with these drugs (6,8,10,13,17-19,21-24,26). Unfortunately, both these well established precipitants of these metabolic complications are also the most frequent adverse outcomes of treatment with SGLT 2 inhibitors(6,13,14,18-20,28-35). Moreover, in elderly subjects, these adverse outcomes are reported to be even more frequent and more serious in nature; men due to concurrent presence of prostatism and post menopausal women because of frequent manifestation of urinary incontinence (36,37). In fact, this observation was the major determinant of the cautions by both the U.S Food and Drug Administration (FDA) and European Medicine Agency (EMA)[38,39]. However, manufacturers of these drugs refuted the significance of these reports by FDA and EMA based on the retrospective analysis of their pre marketing clinical trials (40,41). However, the initial caution by FDA is recently confirmed by a further analysis of larger FDA data base over a long duration as well as the persistent continuing rise in incidence of ketoacidosis following approval and increase in usage of these drugs worldwide as evident by several case series and individual case reports(6-27). Therefore, lack of significant occurrence of Ketoacidosis in these trials as compared to the extensive postmarketing data examined by FDA and EMA may be explained by the fact that the participating subjects in these premarketing clinical trials were healthier and younger because of their selection bias based on several inclusion and exclusion criteria when compared with the population of subjects with type 2 Diabetes, more frequently the elderly with several comorbidities in clinical practice. Furthermore, occurrence of ketosis and/or ketoacidosis may have been missed because of lack of anticipation due to lack of knowledge and therefore lack of laboratory assessment for ketonuria, ketonemia, serum electrolytes and especially arterial blood gases despite onset of marked polyuria, polydipsia, nocturia and dehydration all being well established side effects of drugs themselves as well as occurrence of characteristic manifestations of ketonemia, e.g. nausea, vomiting, abdominal pain, lethargy etc. (1-6,13,14,18-20,28-35). It is also apparent that plasma glucose concentrations were variable ranging from hypoglycemia, euglycemia and hyperglycemia in individual subjects with ketoacidoses administered these drugs(6-27). Presence of ketosis or ketoacidosis was probably not considered in subjects with euglycemia or hypoglycemia despite presenting aforementioned manifestations and therefore was probably overlooked.
Ketoacidosis may be attributed to Diabetes alone though only in subjects with plasma glucose >250 mg/dl as defined by diagnostic criteria established by all Diabetes organizations including American Diabetes Association(1-5,42). Alternatively, ketosis or ketoacidosis in subjects with euglycemia or hypoglycemia must be accounted for by concurrent presence of other disorders. Starvation may be one contributing factor whereas alcoholic ketoacidosis following ethanol intake may be another cause (1-5,9,43-46). Finally, ketoacidosis with hypoglycemia or euglycemia described in some of these subjects may be in fact “Kabadi Syndrome of Pancreatic Ketoacidosis” induced by markedly elevated circulating lipase concentration in acute pancreatitis (47-52) since acute pancreatitis has been described in several reports in the literature(53-55).Thus, It is apparent that occurrence of ketoacidosis secondary to acute pancreatitis was overlooked as well due to lack of determination of serum lipase and amylase concentrations in spite of the presence of classical clinical manifestations, e.g. nausea, vomiting and abdominal pain.
Therefore, it is likely that several known aforementioned pathophysiologic factors may have induced ketosis or ketoacidosis in many subjects receiving SGLT2 inhibitors. However, lack of presence of these pathophysiologic factors or the established precipitants facilitating ketosis or ketoacidosis in many of the subjects in these reports (1-27) may indicate direct pathophysiologic role of the drugs themselves in onset of ketogenesis warranting further examination.
Elevated plasma glucagon level is well documented in subjects with type 2 diabetes and is attributed to lack of glucose entry into pancreatic alpha cells secondary to insulin resistance as well as decline in circulating incretins (56-60). It is apparent that rise in plasma glucagon is further exacerbated in response to a modest decline in circulating glucose due to glycosuria induced by SGLT2 inhibitors (61-65 ). Thus, hyperglucagonemia is deemed to be a compensatory mechanism required to promote hepatic glucose production to compensate for glycosuria [61-70]. However, rise in plasma glucagon is also well established to facilitate lipolysis and ketogenesis with onset of ketonemia and consequential ketonuria(68-70). Moreover, onset of ketoacidosis may also be directly attributed to increased lipolysis and consequential ketogenesis induced by glucagon rise secondary to persistent glycosuria induced by these agents (71-73). Alternatively, dehydration caused by glycosuria on administration of SGLT2 inhibitors is well established to induce prompt stimulation of gluco- counter regulatory hormones, e.g. catecholamines, cortisol. human growth hormone and glucagon and all these hormones are well documented to play a major pathophysiologic role in promoting unrestrained lipolysis and ketogenesis resulting in occurrence of Ketoacidosis (73-75). Finally, several other pathophysiologic mechanisms are being recently implicated in onset of ketosis and ketoacidosis irrespective of the degree of glycemia in subjects administered SGLT 2 inhibitors (77-80).
Unfortunately, ketosis and ketoacidosis are just two of many unacceptable hazards and untoward adverse effects associated with use of SGLT2 inhibitors rendering them relatively unsafe based on risk benefit analysis(28-35). Moreover, additional costs incurred in management of these adverse effects in conjunction with modest efficacy further plummets their cost efficacy. Alternatively, adverse effects and burdensome costs is likely to cause marked decline in quality of life. Fortunately, prompt initiation of well established protocols for management of ketoacidosis assists in reducing morbidity and prevents fatality in most subjects. A prompt cessation of drugs may help prevent recurrent events.
In the final analysis, safety of newly approved drugs is often better established in post marketing surveillance in comparison to premarketing data (81-82). This observation may be attributed to sponsorship and funding of the clinical trials by manufacturers Moreover, their direct involvement rather than the independent organizations in performance of these trials. May also contribute this fact.Alternatively, the discrepancy regarding safety of the drugs between postmarketing surveillance and real world data on one hand and premarketing clinical trials on the other may be attributed to the role of manufacturers in the design of the protocols, their biases as well as their main focus on obtaining a timely approval by the regulatory agencies. In fact, these factors probably contribute to withdrawal of drugs after initial approval by the regulatory agencies. Therefore, both the manufacturers and regulatory agencies must be held accountable and responsible for lack of establishing acceptable degree of safety and premature approval.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
